Ambulatory blood pressure measurement in young normotensive patients with autosomal dominant polycystic kidney disease;Medição ambulatória da pressão arterial em jovens normotensos com doença poliquística renal autossómica dominante

Revista Portuguesa de Cardiologia

Volumn 26, Issue 3, 2007, Pages 235-243

  De Almeida, Edgar A F ^a   De Oliveira, Eduardo I ^a   Lopes, José António ^a   Almeida, Ana G ^a   Lopes, Mário G ^a   Prata, M Martins ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

ABPM; Hypertension; Polycystic kidneys

Indexed keywords

CREATININE;

ADULT; AMBULATORY MONITORING; ARTICLE; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL DOMINANT KIDNEY POLYCYSTIC DISEASE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; ECHOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OUTPATIENT; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; HUMANS; MALE; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT;

EID: 34248196101     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Zerres K. Classification of cystic kidneys in Polycystic Kidney Disease, Michael L Watson e Vicente E Torres (editors), Oxford University Press, 1996.
2. Gabow P: Autosomal Dominant Polycystic Kidney Disease. N Engl J Med 329:332-342, 1993.
3. Reeders ST. A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature 317: 542-544, 1985.
4. Romeo G. A second genetic locus for autosomal dominant polycystic kidney disease. Lancet 2:8-10, 1988.
5. de Almeida S, de Almeida E, Peters D, Pinto JR, Távora I, Lavinha J, Breuning M, Martins Prata, M. Autosomal dominant polycystic kidney disease: evidence for the existence of third locus in a Portuguese family. S de Almeida, E de Almeida, D Peters, J R Pinto, I Távora, J Lavinha, M Breuning, M Martins Prata. Hum Genet 96:83-88, 1995.
6. Wilson PD. Polycystic kidney disease. N Eng J Med 350:151-164, 2004.
7. Torres VE, Wang X, Qian Q, Somlo S, Harris PC, Gattone II V. Effective treatment of an orthologus model of autosomal dominant polycystic kidney disease. Nat Med 10:363-364,2004
8. Torres VE. Vasopressin antagonist in PKD. Kidney Int 68:2405-2418,2005.
9. Ruggenenti P, Remuzzi A, Ondei P, Fasolini G, Amiga L, Enelordache B, et al. Safety and efficacy of long-acting somatostatin treatment of autosomal dominant polycystic kidney disease. Kidney Int 68:206-216,2005.
10. Fick GM, Johnson AM, Hammond WS, Gabow PA. Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 12:2048-2056, 1995.
11. Watson ML: Hypertension in polycystic disease in Watson ML, Torres VE (ed.): Polycystic Kidney Disease, chap 16, Oxford, Oxford Medical Publications, 1996, pp 407-429.
12. Chapman AB, Johnson AN, Rainguet S, Hossack K, Gabow PA, Schrier RW. Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 8:1292-1297,1997.
13. Oflaz H, Alisir S, Buyukaydin B, Kocaman O, Turgut F, Namli S, et al.: Biventricular diastolic dysfunction in patients with ADPKD. Kidney Int 68; 2244-2249, 2005.
14. Lumiaho A, Pihlajamaki J, Harikainen J, Ikaheimo R, Miettinen R, Niemitukia L, et al: Insulin resistance is related to left ventricular hypertrophy in patients with polycystic kidney disease type 1. Am J Kidney Dis 4: 1219-1224, 2003
15. Chapman AB, Johnson AM, Gabow PA, Schrier RW: Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5:1349-1354, 1994.
16. de Almeida E, Lopes JA, Thiran C, Pereira J, Bicho MP, M Martins Prata. Adiponectinémia nos doentes com doenca poliquística renal autossómica dominante: resultados de estudo preliminar (poster). Congresso da Sociedade Portuguesa de Nefrologia, Porto, 2005.
17. Kelleher CL, McFann KK, Johnson AM, Shrier RW: Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared to the general US population. Am J Hypertens 17:1029-1034, 2004.
18. Verdecchia P. Prognostic value of ambulatory blood pressure. Current evidence and clinical implication. Hypertension 35:844-851, 2000.
19. Zeier M, Geberth S, Schmidt KG, Mandelbaum A, Ritz E: Elevated blood pressure profile and left ventricular mass in children and young adults with ADPKD. J Am Soc Nephrol 3: 1451-1457, 1993.
20. Li Kam Va, Macnicol AM, Watson ML: Ambulatory blood pressure in hypertensive patients with autosomal dominant polycystic kidney disease. Nephrol Dial Transpl 12: 2075-2080, 1997.
21. Valero FA, Martinez-Vea A, Bardají A, Gutierrez C, Richart C. Ambulatory blood pressre and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 10; 1020-1026,1999.
22. Ravine D, Gibson RN, Donlan J, Sheffield JL: An ultrasound renal cyst prevalence survey: specificity data for inherited renal cystic diseases. Am J Kidney Dis 22: 803-807, 1993.
23. WHO expert committee report 1980: arterial hypertension - technical report series 628. Geneva. World Health Organization, 1978
24. Pickering T, for an American Society of Hypertension Ad Hoe Panel: Recommendation for the use of self (home) and ambulatory blood pressure monitoring; Am J Hypertens 9: 1-11, 1996.
25. Gabow PA - factors affecting progression of renal disease in autosomal dominant polycystic kidney disease. Kidney Int 41:1311-1319,1992.
26. Klahr S, Breyer J, Beck J, Dennis VW, Hartman JA, Roth D, et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. J Am Soc Nephrol 5:2037-2047, 1995.
27. Schrier RW, McFann RW, Johnson AM, Chapman A, Edelstein C, Brosnahan G, et al. Cardiac and Renal Effects of Standard versus Rigorous Blood Pressure Control in ADPKD: results of a seven-year prospective randomized study. J Am Soc Nephrol 13:1733-1739,2002.
28. Kaplan N. Kaplan's Clinical Hypertension, pg 6-7. Ninth Edition, 2006. Lippincott Williams & Wilkins.